Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid.

Wester A, Devocelle M, Tallant EA, Chappell MC, Gallagher PE, Paradisi F.

Amino Acids. 2017 Oct;49(10):1733-1742. doi: 10.1007/s00726-017-2471-9. Epub 2017 Jul 25.

PMID:
28744580
2.

Programs to Recruit and Retain a More Diverse Workforce in Biomedical Sciences Research.

Gwathmey TM, Tallant EA, Howlett AC, Diz DI.

J Best Pract Health Prof Divers. 2016 Spring;9(1):1188-1194.

3.

Angiotensin-(1-7) Attenuates Skeletal Muscle Fibrosis and Stiffening in a Mouse Model of Extremity Sarcoma Radiation Therapy.

Willey JS, Bracey DN, Gallagher PE, Tallant EA, Wiggins WF, Callahan MF, Smith TL, Emory CL.

J Bone Joint Surg Am. 2016 Jan 6;98(1):48-55. doi: 10.2106/JBJS.O.00545.

PMID:
26738903
4.

Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels.

Carver KA, Smith TL, Gallagher PE, Tallant EA.

Microcirculation. 2015 Jan;22(1):19-27. doi: 10.1111/micc.12159.

PMID:
25079175
5.

Angiotensin-(1-7): a peptide hormone with anti-cancer activity.

Gallagher PE, Arter AL, Deng G, Tallant EA.

Curr Med Chem. 2014;21(21):2417-23. Review.

PMID:
24524765
6.

Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system.

Nautiyal M, Katakam PV, Busija DW, Gallagher PE, Tallant EA, Chappell MC, Diz DI.

Am J Physiol Regul Integr Comp Physiol. 2012 Oct 15;303(8):R799-806. doi: 10.1152/ajpregu.00566.2011. Epub 2012 Aug 22.

7.

Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis.

Krishnan B, Smith TL, Dubey P, Zapadka ME, Torti FM, Willingham MC, Tallant EA, Gallagher PE.

Prostate. 2013 Jan;73(1):71-82. doi: 10.1002/pros.22542. Epub 2012 May 29.

8.

Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.

Krishnan B, Torti FM, Gallagher PE, Tallant EA.

Prostate. 2013 Jan;73(1):60-70. doi: 10.1002/pros.22540. Epub 2012 May 29.

PMID:
22644934
9.

Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.

McCollum LT, Gallagher PE, Tallant EA.

Peptides. 2012 Apr;34(2):380-8. doi: 10.1016/j.peptides.2012.01.020. Epub 2012 Feb 2.

10.

Angiotensin peptides and lung cancer.

Gallagher PE, Cook K, Soto-Pantoja D, Menon J, Tallant EA.

Curr Cancer Drug Targets. 2011 May;11(4):394-404. Review.

11.

Angiotensin peptides and central autonomic regulation.

Diz DI, Arnold AC, Nautiyal M, Isa K, Shaltout HA, Tallant EA.

Curr Opin Pharmacol. 2011 Apr;11(2):131-7. doi: 10.1016/j.coph.2011.02.001. Epub 2011 Feb 28. Review.

12.

Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors.

Cook KL, Metheny-Barlow LJ, Tallant EA, Gallagher PE.

Cancer Res. 2010 Nov 1;70(21):8319-28. doi: 10.1158/0008-5472.CAN-10-1136. Epub 2010 Sep 13.

13.

Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction.

Varagic J, Ahmad S, Brosnihan KB, Groban L, Chappell MC, Tallant EA, Gallagher PE, Ferrario CM.

Ther Adv Cardiovasc Dis. 2010 Feb;4(1):17-25. doi: 10.1177/1753944709353337. Epub 2009 Nov 27.

14.

Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone.

Petty WJ, Miller AA, McCoy TP, Gallagher PE, Tallant EA, Torti FM.

Clin Cancer Res. 2009 Dec 1;15(23):7398-404. doi: 10.1158/1078-0432.CCR-09-1957. Epub 2009 Nov 17.

15.

Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor.

Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA.

Mol Cancer Ther. 2009 Jun;8(6):1676-83. doi: 10.1158/1535-7163.MCT-09-0161. Epub 2009 Jun 9.

16.

Regulation of ACE2 in cardiac myocytes and fibroblasts.

Gallagher PE, Ferrario CM, Tallant EA.

Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2373-9. doi: 10.1152/ajpheart.00426.2008. Epub 2008 Oct 10.

17.

MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.

Gallagher PE, Ferrario CM, Tallant EA.

Am J Physiol Cell Physiol. 2008 Nov;295(5):C1169-74. doi: 10.1152/ajpcell.00145.2008. Epub 2008 Sep 3.

18.

Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.

Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE.

Cancer Res. 2007 Mar 15;67(6):2809-15.

19.

Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.

Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, Gallagher PE, Tallant EA, Cooper SA, Link CD, Ferrario C, Sowers JR.

Am J Physiol Renal Physiol. 2006 Dec;291(6):F1308-14. Epub 2006 Jun 20.

20.

Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.

Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM.

Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2166-72. Epub 2006 Jun 9.

21.

Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart.

Tallant EA, Ferrario CM, Gallagher PE.

Future Cardiol. 2006 May;2(3):335-42. doi: 10.2217/14796678.2.3.335.

PMID:
19804091
22.

Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.

Gallagher PE, Chappell MC, Ferrario CM, Tallant EA.

Am J Physiol Cell Physiol. 2006 Feb;290(2):C420-6. Epub 2005 Sep 21.

23.

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.

Tallant EA, Ferrario CM, Gallagher PE.

Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1560-6. Epub 2005 Jun 10.

24.

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE.

Circulation. 2005 May 24;111(20):2605-10. Epub 2005 May 16.

PMID:
15897343
25.

Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells.

Richmond RS, Tallant EA, Gallagher PE, Ferrario CM, Strawn WB.

J Renin Angiotensin Aldosterone Syst. 2004 Dec;5(4):176-82.

PMID:
15803435
26.

Inhibition of human lung cancer cell growth by angiotensin-(1-7).

Gallagher PE, Tallant EA.

Carcinogenesis. 2004 Nov;25(11):2045-52. Epub 2004 Jul 29.

PMID:
15284177
27.

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.

Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM.

Hypertension. 2004 May;43(5):970-6. Epub 2004 Mar 8.

PMID:
15007027
28.

Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7).

Tallant EA, Clark MA.

Hypertension. 2003 Oct;42(4):574-9. Epub 2003 Sep 2.

PMID:
12953014
29.

Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism.

Clark MA, Tallant EA, Tommasi E, Bosch S, Diz DI.

J Cardiovasc Pharmacol. 2003 Feb;41(2):276-83.

PMID:
12548089
30.

Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells.

Clark MA, Diz DI, Tallant EA.

Hypertension. 2001 Apr;37(4):1141-6.

PMID:
11304516
31.

Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7).

Clark MA, Tallant EA, Diz DI.

J Cardiovasc Pharmacol. 2001 Apr;37(4):437-48.

PMID:
11300657
32.

State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle.

Tallant EA, Diz DI, Ferrario CM.

Hypertension. 1999 Oct;34(4 Pt 2):950-7.

PMID:
10523390
33.

Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats.

Strawn WB, Gallagher PE, Tallant EA, Ganten D, Ferrario CM.

J Cardiovasc Pharmacol. 1999 Mar;33(3):341-51.

PMID:
10069667
34.

Angiotensin-(1-7) reduces smooth muscle growth after vascular injury.

Strawn WB, Ferrario CM, Tallant EA.

Hypertension. 1999 Jan;33(1 Pt 2):207-11.

PMID:
9931106
35.

Angiotensin-(1-7): a novel vasodilator of the coronary circulation.

Brosnihan KB, Li P, Tallant EA, Ferrario CM.

Biol Res. 1998;31(3):227-34. Review.

PMID:
9830510
36.

Counterregulatory actions of angiotensin-(1-7).

Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI.

Hypertension. 1997 Sep;30(3 Pt 2):535-41. Review.

PMID:
9322978
37.
38.

Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor.

Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM.

Hypertension. 1997 Jan;29(1 Pt 2):388-93.

PMID:
9039132
39.

Angiotensin-(1-7) inhibits vascular smooth muscle cell growth.

Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA.

Hypertension. 1996 Jul;28(1):104-8.

PMID:
8675248
40.

Identification of AT1 receptors on cultured astrocytes.

Tallant EA, Diz DI, Ferrario CM.

Adv Exp Med Biol. 1996;396:121-9. Review. No abstract available.

PMID:
8726692
41.
42.

Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats.

Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, Ferrario CM.

Hypertension. 1995 Jun;25(6):1260-5.

PMID:
7768571
43.

Role of calcium and protein kinase C in the activation of phospholipase D by angiotensin II in vascular smooth muscle cells.

Freeman EJ, Chisolm GM, Tallant EA.

Arch Biochem Biophys. 1995 May 10;319(1):84-92.

PMID:
7771808
44.

Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells.

Chappell MC, Jacobsen DW, Tallant EA.

Peptides. 1995;16(4):741-7.

PMID:
7479311
45.
46.

Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells.

Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM.

Hypertension. 1993 Jun;21(6 Pt 2):900-5.

PMID:
8505098
47.
48.

Angiotensin-(1-7): a new hormone of the angiotensin system.

Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA.

Hypertension. 1991 Nov;18(5 Suppl):III126-33. Review.

PMID:
1937675
49.

Human astrocytes contain two distinct angiotensin receptor subtypes.

Tallant EA, Jaiswal N, Diz DI, Ferrario CM.

Hypertension. 1991 Jul;18(1):32-9.

PMID:
1860709
50.

Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells.

Tallant EA, Diz DI, Khosla MC, Ferrario CM.

Hypertension. 1991 Jun;17(6 Pt 2):1135-43.

PMID:
2045160

Supplemental Content

Loading ...
Support Center